Vanguard Group Inc. Purchases 19,635 Shares of Surmodics, Inc. (NASDAQ:SRDX)

Vanguard Group Inc. lifted its position in Surmodics, Inc. (NASDAQ:SRDX) by 2.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 846,164 shares of the company’s stock after purchasing an additional 19,635 shares during the quarter. Vanguard Group Inc. owned about 0.06% of Surmodics worth $27,153,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in SRDX. Kennedy Capital Management LLC increased its holdings in shares of Surmodics by 227.7% in the second quarter. Kennedy Capital Management LLC now owns 293,359 shares of the company’s stock worth $9,185,000 after purchasing an additional 203,832 shares during the last quarter. Susquehanna International Group LLP purchased a new position in Surmodics in the first quarter worth about $4,585,000. Arrowstreet Capital Limited Partnership purchased a new position in Surmodics in the first quarter worth about $2,650,000. Jane Street Group LLC purchased a new position in Surmodics in the first quarter worth about $2,059,000. Finally, Cubist Systematic Strategies LLC purchased a new position in Surmodics in the first quarter worth about $1,763,000. 96.63% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reiterated a “buy” rating and issued a $47.00 price target on shares of Surmodics in a research report on Wednesday.

Surmodics Stock Down 2.5 %

Shares of NASDAQ:SRDX opened at $27.00 on Friday. Surmodics, Inc. has a 1 year low of $16.79 and a 1 year high of $39.41. The business has a 50 day simple moving average of $29.91 and a two-hundred day simple moving average of $32.02. The firm has a market capitalization of $384.37 million, a PE ratio of 71.05 and a beta of 1.01. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.84 and a quick ratio of 3.97.

Surmodics Company Profile

Surmodics, Inc, together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD).